STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
25.41
+0.47 (1.88%)
At close: Aug 12, 2026, 4:00 PM EDT
24.92
-0.49 (-1.93%)
After-hours: Aug 12, 2026, 7:59 PM EDT
STAAR Surgical Company Balance Sheet
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 148.58 | 153.15 | 144.16 | 183.04 | 86.48 | 199.71 |
Short-Term Investments | 32.91 | 34.39 | 86.34 | 37.69 | 125.16 | - |
Cash & Short-Term Investments | 181.49 | 187.54 | 230.49 | 220.73 | 211.64 | 199.71 |
Cash Growth | -4.42% | -18.64% | 4.42% | 4.29% | 5.97% | 31.00% |
Accounts Receivable | 98.48 | 50.06 | 77.9 | 94.7 | 62.45 | 43.53 |
Inventory | 46.84 | 55.5 | 43.31 | 35.13 | 24.16 | 17.27 |
Other Current Assets | 15.55 | 18.45 | 16.24 | 14.71 | 13.48 | 10.9 |
Total Current Assets | 342.35 | 311.55 | 367.94 | 365.27 | 311.72 | 271.41 |
Net Property, Plant & Equipment | 97.44 | 102.93 | 121.78 | 101.41 | 81.53 | 67.73 |
Other Intangible Assets | 31.32 | 30.7 | 15.76 | - | 0.17 | 0.22 |
Goodwill | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 |
Long-Term Investments | - | - | - | 11.7 | 13.9 | - |
Other Long-Term Assets | 2.31 | 4.72 | 2.26 | 8.53 | 9.7 | 4.64 |
Total Assets | 475.21 | 451.68 | 509.52 | 488.69 | 418.82 | 345.78 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 13.48 | 11.57 | 16.7 | 13.56 | 11.58 | 8.7 |
Current Portion of Leases | 6.18 | 5.87 | 3.94 | 4.37 | 3.69 | 3.41 |
Unearned Revenue | 16.2 | 10.2 | 6.58 | 6.17 | 5.71 | 4.82 |
Other Current Liabilities | 37.54 | 40.86 | 43.09 | 40.94 | 30.74 | 31.88 |
Total Current Liabilities | 73.39 | 68.5 | 70.31 | 65.04 | 51.72 | 48.8 |
Long-Term Leases | 29.77 | 32.48 | 34.81 | 31.47 | 27.35 | 28.65 |
Other Long-Term Liabilities | 6.65 | 6.51 | 7.08 | 6.24 | 3.64 | 9.77 |
Total Long-Term Liabilities | 36.41 | 38.99 | 41.88 | 37.7 | 30.99 | 38.42 |
Total Liabilities | 109.81 | 107.49 | 112.19 | 102.74 | 82.71 | 87.22 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.51 | 0.5 | 0.49 | 0.49 | 0.48 | 0.48 |
Treasury Stock | -6.46 | -6.46 | - | - | - | - |
Additional Paid-in Capital | 513.08 | 504.68 | 471.45 | 436.95 | 404.19 | 373.52 |
Accumulated Other Comprehensive Income | -6.97 | -6.51 | -7.03 | -4.11 | 0.16 | -4.05 |
Retained Earnings | -134.76 | -148.02 | -67.58 | -47.37 | -68.72 | -111.39 |
Shareholders' Equity | 365.4 | 344.18 | 397.34 | 385.95 | 336.11 | 258.56 |
Total Liabilities & Equity | 475.21 | 451.68 | 509.52 | 488.69 | 418.82 | 345.78 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 3, 2026 | Jan '26 Jan 2, 2026 | Dec '24 Dec 27, 2024 | Dec '23 Dec 29, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 35.94 | 38.35 | 38.74 | 35.83 | 31.04 | 32.06 |
Net Cash (Debt) | 145.55 | 149.18 | 191.75 | 184.89 | 180.6 | 167.65 |
Net Cash Growth | -2.55% | -22.20% | 3.71% | 2.38% | 7.73% | 18.35% |
Net Cash Per Share | 2.87 | 3.01 | 3.90 | 3.74 | 3.66 | 3.39 |
Book Value | 365.4 | 344.18 | 397.34 | 385.95 | 336.11 | 258.56 |
Book Value Per Share | 7.21 | 6.94 | 8.09 | 7.81 | 6.81 | 5.23 |
Tangible Book Value | 332.29 | 311.7 | 379.79 | 384.17 | 334.15 | 256.55 |
Tangible Book Value Per Share | 6.56 | 6.29 | 7.73 | 7.77 | 6.77 | 5.19 |